2020, November 16-18: Challenges in Hematopathology
November 16-18, 2020 - Palm Springs, California
12 CME / 12 SAMs
Distinguishing between reactive and neoplastic proliferations in blood, bone marrow, lymph nodes, spleen and extra-nodal hematopoietic tissues, as well as accurately classifying neoplasms once they are identified, are essential for appropriate patient care. Pathologists struggle with differentiating reactive from neoplastic conditions in these organs, as well as in properly classifying hematopoietic neoplasms once they are diagnosed. This highly respected expert faculty will provide a unique mentoring experience in an intimate study environment at USCAP’s Interactive Learning Center. They intend to cover diagnostic criteria for new entities in the 2016 WHO Classification of Hematopoietic and Lymphoid Neoplasms and provide useful morphologic clues and ancillary techniques to help you distinguish neoplastic and reactive conditions.
- Become familiar with new and rare disease entities involving blood and hematopoietic tissues
- Understand the changes caused by reactive and specific infectious agents in hematopoietic tissues
- Understand the spectrum of Hodgkin lymphoma and its mimics
- Incorporate the clues and ancillary techniques to differentiate neoplastic from reactive proliferations in blood, bone marrow, lymph nodes, spleen and extra-nodal hematopoietic tissues
- Daniel A. Arber, MD
University of Chicago
- M. Kathryn Foucar, MD
University of New Mexico
- Rebecca L. King, MD
- Girish Venkataraman, MD, MBBS
University of Chicago
CONTINUING MEDICAL EDUCATION AND CONTINUING CERTIFICATION
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this live activity for a maximum of 12 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC).
Physicians can earn a maximum of 12 SAM/Part II credit hours.
USCAP records courses at the Interactive Learning Center for future educational purposes. By registering for this course, you consent that your likeness may be used by USCAP.
In the context of the pandemic crisis, USCAP is indefinitely suspending its cancellation policy on all scheduled and upcoming courses until there is a resolution or return to normalcy. However, we encourage you to register (without penalty) for advertised courses (months ahead) in anticipation of return to face-to-face conferences. You can secure your position in advance and cancel, if necessary, with full refund.
The Academy is not responsible for travel expenses incurred as a result of an event cancellation.